Wolverine Trading
ANIP icon

Wolverine Trading’s ANI Pharmaceuticals ANIP Stock Holding History

Wolverine Trading’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,200
Closed -$221K – 4426
2024
Q1 		$221K Buy
+3,200
New +$193K ﹤0.01% 3685
2021
Q1 		– Sell
-10,100
Closed -$289K – 5803
2020
Q4 		$289K Buy
+10,100
New +$289K ﹤0.01% 3789
2018
Q4 		– Sell
-5,100
Closed -$288K – 4367
2018
Q3 		$288K Sell
5,100
-3,000
-37% -$184K ﹤0.01% 3778
2018
Q2 		$472K Hold
8,100
– – ﹤0.01% 3163
2018
Q1 		$472K Buy
+8,100
New +$514K ﹤0.01% 3163
2017
Q3 		– Sell
-6,100
Closed -$288K – 4370
2017
Q2 		$288K Sell
6,100
-7,600
-55% -$367K ﹤0.01% 3108
2017
Q1 		$680K Buy
+13,700
New +$769K ﹤0.01% 2065
2016
Q3 		– Sell
-25,700
Closed -$1.44M – 4568
2016
Q2 		$1.44M Buy
+25,700
New +$1.25M 0.01% 1326

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's ANIP Position: Q1 2018 in Review

Wolverine Trading sold out of ANI Pharmaceuticals (ANIP) in Q1 2018, closing a stake of 7,278 shares — an estimated $462K sold.

Wolverine Trading first reported a position in ANIP in Q4 2016 and held it in 4 quarters. The position peaked at $469K in Q4 2017. 175 funds tracked by Wall St. Rank hold ANIP as of Q1 2018.

  • Wolverine Trading reported no remaining ANI Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Wolverine Trading sold 7,278 ANI Pharmaceuticals shares in Q1 2018, an estimated $462K.
  • Wolverine Trading first reported a position in ANI Pharmaceuticals in Q4 2016 and held it in 4 quarters.
  • Wolverine Trading's ANI Pharmaceuticals position peaked at $469K in Q4 2017.
  • 175 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2018.

Based on Wolverine Trading's 13F filing for Q1 2018, filed 15 May 2018.